The company has produced a wearable head sensor and software that allows therapists to prescribe and track exercises carried out by patients, monitor patient symptoms and therefore gain insights into the effectiveness of treatments.The funding will lead to the creation of 10 new jobs and will help the team to continue product development and expand into the UK and US markets.
"Worldwide, patients who have been diagnosed with vertigo can face months-long waiting lists or an inability to get access to treatment at all," said Mark Barry, CEO, Vertigenius. Atlantic Bridge led the funding round, which also included investments from Ascentifi and Enterprise Ireland.
Vi har sammanfattat den här nyheten så att du kan läsa den snabbt. Om du är intresserad av nyheterna kan du läsa hela texten här. Läs mer: